40				EUR
NAT	Filing date	Nr.	U.	D.

ANNUAL ACCOUNTS AND OTHER DOCUMENTS TO BE FILED UNDER BELGIAN COMPANY LAW

IDENTIFICATION DETAILS

NAME:
Legal form: Public limited company
Address: Allée de la Recherche
Postal code: Municipality: Anderlecht
Country: Belgium
Register of legal persons - commercial court Brussels, French-speaking
Website address !
Company identification number BE 0403.053.608
DATE the date of publication of the memorandum of association and of the act amending the articles of association.
ANNUAL ACCOUNTS ANNUAL ACCOUNTS IN EUROS approved by the general meeting of 26 / 04 / 2017
01 / 01 / 2016 / to to Regarding the financial year from 31 / 12 / 2016
Preceding financial year from 01 01 / 01 / 2015 to 31 / 12 / 2015
The amounts for the preceding period are / and one identical to the ones previously published.

Total number of pages filed: ........................ Numbers of sections of the standard form not filed because they serve no useful purpose: .....................................................................................................................................................................

Jean-Christophe TELLIER Director

Gerhard MAYR Chairman of the Board of Directors

1 Optional information.
2 Strike out what is not applicable.

LIST OF DIRECTORS, BUSINESS MANAGERS AND AUDITORS AND DECLARATION REGARDING A COMPLIMENTARY REVIEW OR CORRECTION ASSIGNMENT

LIST OF THE DIRECTORS, BUSINESS MANAGERS AND AUDITORS

COMPLETE LIST with surname, first names, profession, place of residence (address, number, postal code and municipality) and position within the company

Gerhard MAYR c/o UCB S.A. Allée de la Recherche 60, 1070 Anderlecht, Belgium	Chairr
Evelyn JANSSEN épse de D. du MONCEAU de BERGENDAL c/o UCB S.A. Allée de la Recherche 60, 1070 Anderlecht, Belgíum	Vice-c
Jean-Christophe TELLIER c/o UCB S.A. Allée de la Recherche 60, 1070 Anderlecht, Belgium	Direct
Alice DAUTRY c/o UCB S.A. Allée de la Recherche 60, 1070 Anderlecht, Belgium	Direct
Kay DAVIES c/o UCB S.A. Allée de la Recherche 60, 1070 Anderlecht, Belgium	Direct
Albrecht DE GRAEVE c/o UCB S.A. Allée de la Recherche 60, 1070 Anderlecht, Belgium	Direct
Harriet EDELMAN c/o UCB S.A. Allée de la Recherche 60, 1070 Anderlecht, Belgium	Direct
Pierre GURDJIAN c/o UCB S.A. Allée de la Recherche 60, 1070 Anderlecht, Belgium	Direct 28/04
Charles-Antoine JANSSEN c/o UCB S.A. Allée de la Recherche 60, 1070 Anderlecht, Belgium	Direct
Cyril JANSSEN c/o UCB S.A. Allée de la Recherche 60, 1070 Anderlecht, Belgium	Direc
Tom McKILLOP c/o UCB S.A. Allée de la Recherche 60, 1070 Anderlecht, Belgium	Direc - 28/0
Norman J. ORNSTEIN c/o UCB S.A. Allée de la Recherche 60, 1070 Anderlecht, Belgium	Direc
Cédric van RIJCKEVORSEL c/o UCB S.A. Allée de la Recherche 60, 1070 Anderlecht, Belgium	Direc
Uf WINBERG c/o UCB S.A. Allée de la Recherche 60, 1070 Anderlecht, Belgium	Direc 28/04
PwC Réviseurs d'Entreprises SCCRL Nr .: BE 0429.501.944 Woluwe Garden Woluwedal 18, 1932 Sint-Stevens-Woluwe, Belgium Membership nr.: B00009	Audit
Represented by:
Romain SEFFER 14 lokusedal 10 40:00 Oint Stovenno Malumon Balmium

Membership nr.: A02047

man of the board of directors

chairman of the board of directors

tor

ctor 1/2016 -

ctor

tor 04/2016

tor

ctor

ctor 4/2016 -

tor

F 2.1

-----------------------------------------------------------------------------------------------------------------------

DECLARATION REGARDING A COMPLIMENTARY REVIEW OR CORRECTION ASSIGNMENT

The managing board declares that no audit or correction assignment has been given to a person who was not authorised to do so by law, pursuant to art. 34 and 37 of the law of 22th April 1999 concerning accounting and tax professions.

The annual accounts Mere not audited or corrected by an external accountant or by a company auditor who is not the statutory auditor.

If affirmative, mention hereafter: surnames, profession and address of each external accountant or company auditor and his membership number with his Institute as well as the nature of his assignment:

A. Bookkeeping of the enterprise **,
B. Preparing the annual accounts **,
C. Auditing the annual accounts and/or
D. Correcting the annual accounts.

If the tasks mentioned under A. or B. are executed by certified bookkeepers - tax specialists, you can mention hereafter: surname, first names, profession and address of each certified bookkeeper - tax specialist and his/her affiliation number with the Institute of Accounting Professional and Tax Experts and the nature of his/her assignment.

Surname, first names, profession and address	Affiliation number	Nature of the assignment (A, B, C and/or D)

Strike out what is not applicable.

^** Optional information.

ANNUAL ACCOUNTS

BALANCE SHEET AFTER APPROPRIATION

	Discl.	Codes	Period	Preceding period
ASSETS
Formation expenses	6.1	20	15.679.970	20.068.665
FIXED ASSETS		21/28	4.790.528.594	7.734.535.587
Intangible fixed assets	6.2	21	393.656	119.586
Tangible fixed assets	6.3	22/27	7.503.811	7.631.922
Land and buildings		22	5.809.884	5.867.452
Plant, machinery and equipment		23	974.733	718.206
Furniture and vehicles		24	207.275	271.632
Leasing and similar rights		25	.
Other tangible fixed assets		26	.
Assets under construction and advance payments		27	511.919	774.632
Financial fixed assets		28	4.782.631.127	7.726.784.079
Affiliated enterprises		280/1	4.767.452.752	7.711.460.995
Participating interests		280	4.767.452.752	7.711.460.995
Amounts receivable		281
Other enterprises linked by participating interests	6.15	282/3	15.126.590	15.126.591
Participating interests		282	15.126.590	15.126.591
Amounts receivable		283
Other financial assets		284/8	51.785	196.493
Shares		284	51.785	196.493
Amounts receivable and cash guarantees		285/8

F 3.1 |

Nr. BE 0403.053.608			F 3.1
	Discl. Codes	Period	Preceding period
CURRENT ASSETS	29/58	3.195.628.967	1.408.998.439
Amounts receivable after more than one year Trade debtors	29 290	2.145.108.433	1.048.786.841
Other amounts receivable	291	2.145.108.433	1.048.786.841
Stocks and contracts in progress Stocks	3 30/36
Raw materials and consumables	30/31
Work in progress	32
Finished goods	33
Goods purchased for resale	34
Immovable property intended for sale	35
Advance payments	રૂક
Contracts in progress	37	.
Amounts receivable within one year	40/41	633.833.969	46.036.042
Trade debtors	40	17.794.359	45.006.424
Other amounts receivable	41	616.039.610	1.029.618
Current investments	20123	153.019.315	201.367.660
Own shares	50	141.173.133	189.521.478
Other investments	51/53	11.846.182	11.846.182
Cash at bank and in hand	54/58	29 147 252	92.581.653
Deferred charges and accrued income	490/1 6.6	234.519.998	20.226.243
TOTAL ASSETS -----------------------------------------------------------------------------------------------------------------------------------------------------------------	20158	8.001.837.531	9.163.602.691

Nr. BE 0403.053.608				F 3.2
	Discl.	Codes	Period	Preceding period
EQUITY AND LIABILITIES
EQUITY		10/15	5.736.650.206	5.796.167.329
Capital Issued capital Uncalled capital		10 100 101	583.516.974 583.516.974	583.516.974 583.516.974
Share premium account		11	1.999.541.662	1.999.541.661
Revaluation surpluses		12
Reserves Legal reserve Reserves not available In respect of own shares held Other Untaxed reserves Available reserves Accumulated profits (losses) Investment grants		13 130 131 1310 1311 132 133 14 15	3.153.591.570 58.351.697 141.173.133 141.173.133 2.954.066.740	3.213.108.694 58.351.698 189.521.479 189.521.479 . 2.965.235.517
Advance to associates on the sharing out of the assets		19
PROVISIONS AND DEFERRED TAXES		16	47.637.011	56.395.617
Provisions for liabilities and charges Pensions and similar obligations Taxation Major repairs and maintenance Environmental obligations Other liabilities and charges		160/5 160 161 162 163 164/5	47.637.011 333.569 47.303.442	56.395.617 791.971 55.603.646
Doforron tovoc		168

Nr. BE 0403.053.608				F 3.2
	Disci.	Codes	Period	Preceding period
AMOUNTS PAYABLE		17/49	2.217.550.314	3.311.039.745

Amounts payable after more than one year	6.9	17	1.526.567.953	1.310.503.494
Financial debts		170/4	1.526.567.953	1.292.747.186
Subordinated loans		170
Unsubordinated debentures		171	1.200.717.000	1.200.717.000
Leasing and other similar obligations		172
Credit institutions		173
Other loans		174	325.850.953	92.030.186
Trade debts		175
Suppliers		1750
Bills of exchange payable		1751
Advances received on contracts in progress		176	.
Other amounts payable		178/9		17.756.308
Amounts payable within one year		42/48	601.453.359	1.922.998.298
Current portion of amounts payable after more than one year				800.000.000
falling due within one year		42	328.022.671	848.648.230
Financial debts		43	3.327	487.030.717
Credit institutions		430/8	328.019.344	361.617.513
Other loans		439		33.879.064
Trade debts		44	18.142.837
Suppliers		440/4	18.142.837	33.879.064
Bills of exchange payable		441
Advances received on contracts in progress		46
Taxes, remuneration and social security	6.9	45	20.744.252	14.768.511
Taxes		450/3	10.350.445	7.333.308
Remuneration and social security		454/9	10.393.807	7.435.203
Other amounts payable		47/48	234.543.599	225.702.493
Accruals and deferred income	6.9	492/3	89.529.002	77.537.953
TOTAL LIABILITIES		10/49	8.001.837.531	9.163.602.691

Nr

BE 0403.053.608

INCOME STATEMENT

	Discl.	Codes	Period	Preceding period
Operating income		70/76A	69.990.026	90.940.379
Turnover	6.10	70
Stocks of finished goods and work and contracts in progress:
increase (decrease)		71
Own work capitalised		72	660
Other operating income		74	69.989.366	90.940.379
Non-Recurring Operating Income		76A
Operating charges		60/66A	117.459.062	151.083.590
Raw materials, consumables		60
Purchases		600/8
Stocks: decrease (increase)		609
Services and other goods		61	44.315.007	63.796.376
Remuneration, social security costs and pensions (+)/(-) 6.10		62	77.364.265	76.223.580
Depreciation of and other amounts written off formation
expenses, intangible and tangible fixed assets		630	2.373.373	3.265.860
Amounts written off stocks, contracts in progress and trade
debtors: Appropriations (write-backs) (+)/(-) 6.10		631/4	4.773	-2.155
Provisions for liabilities and charges: Appropriations (uses
and write-backs)	6.10	635/8	-8.131.607	5.568.895
Other operating charges	6.10	640/8	2.160.251	1.604.034
Operating charges carried to assets as restructuring costs (-)		649
Non-recurring operating charges		66A	-627.000	627.000
Operating profit (loss)		9901	-47.469.036	-60.143.211

F 4 |

Nr. BE 0403.053.608				E 4
	Discl.	Codes	Period	Preceding period
Financial income		75/76B	472.984.064	387.961.541
Recurring financial income		75 750	447.789.571 248.763.549	387.961.541 250.617.911
Income from financial fixed assets Income from current assets		751	114.925.714	97.845.718
Other financial income	6.11	752/9	84.100.308	39.497.912
Non-recurring financial income	6.12	76B	25.194.493
Financial charges Financial charges Debt charges	6.11	65/66B રિક 650	263.773.182 263.773.182 91.775.816	155.240.950 155.240.950 111.793.921
Amounts written off current assets except stocks, contracts in progress and trade debtors: appropriations (write-backs) . Other financial charges Non-recurring financial charges		651 652/9 66B	84.560.529 87.436.837	41.865.494 1.581.535
Gain (loss) for the period before taxes		8903	161.741.846	172.577.380
Transfer from deferred taxes		780
Transfer to deferred taxes		680
lncome taxes	6.13	67177	1.118.928	935.932
Taxes		670/3	1.118.998	935.932
Adjustment of income taxes and write-back of tax provisions		77	70
Gain (loss) of the period		9904	160.622.918	171.641.448
Transfer from untaxed reserves		789
Transfer to untaxed reserves		689
Gain (loss) of the period available for appropriation (+) (-)		9805	160.622.918	171.641.448

Nr. BE 0403.053.608

APPROPRIATION ACCOUNT

	Codes	Period	Preceding period
Profit (loss) to be appropriated	9906	160.622.918	190.516.417
Gain (loss) of the period available for appropriation	(9905)	160.622.918	171.641.448
Accumulated profits (losses)	14P		18.874.969
Withdrawals from capital and reserves	791/2	59.517.122	19.367.551
from capital and share premium account	791
from reserves	792	59.517.122	19.367.551
Transfer to capital and reserves	691/2
to capital and share premium account	691
to legal reserve	6920
to other reserves	6921
Accumulated profits (losses)	(14)
Owners' contribution in respect of losses
Profit to be distributed	694/7	220.140.040	209.883.968
Dividends	694	220.140.040	209.883.968
Directors' or managers' entitlements	695	.
Employees	୧୫୧
Other beneficiaries	697

F 5

BE 0403.053.608

F 6.1 |

EXPLANATORY DISCLOSURES

STATEMENT OF FORMATION EXPENSES

	Codes	Period	Preceding period
Formation expenses		XXXXXXXXXXXXXXXXXXXX	20.068.665
Movements during the period
New expenses incurred		10.898
Depreciation		4.399.593
Other	8004	.
Formation expenses		15.679.970
Of which
Formation or capital increase expenses, loan issue expenses and other tormation expenses		15.679.970
Restructuring costs		.

Nr. BE 0403.053.608			F 6.2.3
	Codes	Period	Preceding period
CONCESSIONS, PATENTS, LICENCES, KNOW-HOW, BRANDS AND SIMILAR RIGHTS
Acquisition value at the end of the period		XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX	1.007.853
Movements during the period
Acquisitions, including produced fixed assets		55.425
Sales and disposals	8032
Transfers from one heading to another	8042	273.186
Acquisition value at the end of the period	8052	1-336.464
Depreciations and amounts written down at the end of the period	8122P	XXXXXXXXXXXXXXXXXXX	888.267
Movements during the period
Recorded	8072	54.541
Written back	8082
Acquisitions from third parties	8092
Cancelled owing to sales and disposals	8102
Transferred from one heading to another (+)/(-)	8112
Depreciations and amounts written down at the end of the period	8122	942.808
NET BOOK VALUE AT THE END OF THE PERIOD	211	393.656

Nr.	BE 0403.053.608				F 6.2.4
			Codes	Period	Preceding period
GOODWILL
		Acquisition value at the end of the period		XXXXXXXXXXXXXXXXXXXX	18.283.336
	Movements during the period
		Acquisitions, including produced fixed assets	8023
	Sales and disposals		8033
	Transfers from one heading to another		8043
	Acquisition value at the end of the period		8053	18.283.336
	Depreciations and amounts written down at the end of the period		8123P	XXXXXXXXXXXXXXXXXXXX	18.283.336
	Movements during the period
		Recorded	8073
	Written back		8083
		Acquisitions from third parties
	Cancelled owing to sales and disposals		8103
	Transferred from one heading to another		8113
	Depreciations and amounts written down at the end of the period		8123	18.283.336
		NET BOOK VALUE AT THE END OF THE PERIOD	212

Nr.

F 6.3.1

STATEMENT OF TANGIBLE FIXED ASSETS

	Codes	Period	Preceding period
LAND AND BUILDINGS
Acquisition value at the end of the period	8191P	XXXXXXXXXXXXXXXXXXXX	6.449.354
Movements during the period
Acquisitions, including produced fixed assets	8161
Sales and disposals	8171
Transfers from one heading to another	8181	.
Acquisition value at the end of the period	8191	6.449.354
Revaluation surpluses at the end of the period	8251P	XXXXXXXXXXXXXXXXXXXXX
Movements during the period
Recorded	8211
Acquisitions from third parties
Cancelled	8231
Transferred from one heading to another	8241
Revaluation surpluses at the end of the period	8251
Depreciations and amounts written down at the end of the period	8321P	XXXXXXXXXXXXXXXXXXXX	581.901
Movements during the period
Recorded	8271	57.569
Written back	8281
Acquisitions from third parties	8291
Cancelled owing to sales and disposals	8301
Transferred from one heading to another	8311
Depreciations and amounts written down at the end of the period	8321	639.470
NET BOOK VALUE AT THE END OF THE PERIOD	(22)	5.809.884

Nr. BE 0403.053.608			F 6.3.2
	Codes	Period	Preceding period
PLANT, MACHINERY AND EQUIPMENT
Acquisition value at the end of the period		XXXXXXXXXXXXXXXXXXXXX	1.040.044
Movements during the period
Acquisitions, including produced fixed assets		63.572
Sales and disposals
Transfers from one heading to another	8182	382.685
Acquisition value at the end of the period	8192	1.486.301
Revaluation surpluses at the end of the period		XXXXXXXXXXXXXXXXXXXX
Movements during the period
Recorded
Acquisitions from third parties
Cancelled
Transferred from one heading to another	8242
Revaluation surpluses at the end of the period	8252
Depreciations and amounts written down at the end of the period	8322P	XXXXXXXXXXXXXXXXXXXX	321.839
Movements during the period
Recorded		189.729
Written back
Acquisitions from third parties	8292
Cancelled owing to sales and disposals	8302
Transferred from one heading to another	8312
Depreciations and amounts written down at the end of the period	8322	511.568
NET BOOK VALUE AT THE END OF THE PERIOD	(23)	974.733

Nr. BE 0403.053.608			F 6.3.3
	Codes	Period	Preceding period
FURNITURE AND VEHICLES
Acquisition value at the end of the period	8193P	XXXXXXXXXXXXXXXXXXXX	5.396.560
Movements during the period
Acquisitions, including produced fixed assets		30.217
Sales and disposals	8173
Transfers from one heading to another	8183
Acquisition value at the end of the period	8193	5.426.777
Revaluation surpluses at the end of the period	8253P	XXXXXXXXXXXXXXXXXXXX
Movements during the period
Recorded	8213
Acquisitions from third parties
Cancelled	8233
Transferred from one heading to another	8243
Revaluation surpluses at the end of the period	8253
Depreciations and amounts written down at the end of the period	8323P	XXXXXXXXXXXXXXXXXXXX	5.124.928
Movements during the period
Recorded	8273	94.574
Written back	8283
Acquisitions from third parties	8293
Cancelled owing to sales and disposals	8303
Transferred from one heading to another	8313
Depreciations and amounts written down at the end of the period	8323	5.219.502
NET BOOK VALUE AT THE END OF THE PERIOD	(24)	207.275

Nr. BE 0403.053.608			F 6.3.5
	Codes	Period	Preceding period
OTHER TANGIBLE FIXED ASSETS
Acquisition value at the end of the period		XXXXXXXXXXXXXXXXXXXX	1.418.240
Movements during the period
Acquisitions, including produced fixed assets
Sales and disposals
Transfers from one heading to another	8185
Acquisition value at the end of the period	8195	1.418.240
Revaluation surpluses at the end of the period		XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Movements during the period
Recorded
Acquisitions from third parties
Cancelled	8235
Transferred from one heading to another	8245
Revaluation surpluses at the end of the period	8255
Depreciations and amounts written down at the end of the period	8325P	XXXXXXXXXXXXXXXXXXXXX	1.418.240
Movements during the period
Recorded
Written back
Acquisitions from third parties
Cancelled owing to sales and disposals	8305
Transferred from one heading to another	8315
Depreciations and amounts written down at the end of the period	8325	1.418.240
NET BOOK VALUE AT THE END OF THE PERIOD	(26)

Nr. BE 0403.053.608			F 6.3.6
	Codes	Period	Preceding period
ASSETS UNDER CONSTRUCTION AND ADVANCE PAYMENTS
Acquisition value at the end of the period		XXXXXXXXXXXXXXXXXXX	774.632
Movements during the period Acquisitions, including produced fixed assets Sales and disposals	8176	393.158 -655.871
Transfers from one heading to another	8186
Acquisition value at the end of the period	8196	511.919
Revaluation surpluses at the end of the period	8256P	XXXXXXXXXXXXXXXXXXX
Movements during the period Recorded Acquisitions from third parties Cancelled Transferred from one heading to another	8236 8246
Revaluation surpluses at the end of the period	8256
Depreciations and amounts written down at the end of the period	8326P	XXXXXXXXXXXXXXXXXXXXX
Movements during the period Recorded Written back Acquisitions from third parties Cancelled owing to sales and disposals Transferred from one heading to another	8286 8296 8306 8316
Depreciations and amounts written down at the end of the period	8326
NET BOOK VALUE AT THE END OF THE PERIOD	(27)	511.919

Nr. BE 0403.053.608

F 6.4.1 |

STATEMENT OF FINANCIAL FIXED ASSETS

	Codes	Period	Preceding period
AFFILIATED ENTERPRISES - PARTICIPATING INTERESTS AND SHARES
Acquisition value at the end of the period	8391P	XXXXXXXXXXXXXXXXXXXX	7.748.384.465
Movements during the period
Acquisitions	8361	1.550.938.790
Sales and disposals	8371	4.432.704.688
Transfers from one heading to another	8381
Acquisition value at the end of the period	8391	4.866.618.567
Revaluation surpluses at the end of the period	8451P	XXXXXXXXXXXXXXXXXXXX
Movements during the period Recorded	8411
Acquisitions from third parties
Cancelled	8431
Transferred from one heading to another	8441
Revaluation surpluses at the end of the period	8451
Amounts written down at the end of the period	8521P	XXXXXXXXXXXXXXXXXXX	36.923.472
Movements during the period
Recorded	8471	87.436.836
Written back	8481	25.194.493
Acquisitions from third parties	8491
Cancelled owing to sales and disposals	8501
Transferred from one heading to another	8511
Amounts written down at the end of the period	8521	99.165.815
Uncalled amounts at the end of the period	8551P	XXXXXXXXXXXXXXXXXXXX
Movements during the period	8541
Uncalled amounts at the end of the period	8551
NET BOOK VALUE AT THE END OF THE PERIOD	(280)	4.767.452.752
AFFILIATED ENTERPRISES - AMOUNTS RECEIVABLE
NET BOOK VALUE AT THE END OF THE PERIOD		XXXXXXXXXXXXXXXXXXX
Movements during the period
Additions	8581
Repayments
Amounts written down	8601
Amounts written back	8611
Exchange differences	8621
Other movements	8631
NET BOOK VALUE AT THE END OF THE PERIOD
ACCUMULATED AMOUNTS WRITTEN OFF AMOUNTS RECEIVABLE AT END OF THE PERIOD	8651

Nr	BF 0403 053 608 אות העיר המוני

	Codes	Period	Preceding period
ENTERPRISES LINKED BY A PARTICIPATING INTEREST - PARTICIPATING INTERESTS AND SHARES
Acquisition value at the end of the period	8392P	XXXXXXXXXXXXXXXXXXXX	15.126.591
Movements during the period
Acquisitions	8362
Sales and disposals	8372
I ransters from one heading to another	8382
Acquisition value at the end of the period	8392	15.126.591
Revaluation surpluses at the end of the period	8452P	XXXXXXXXXXXXXXXXXXXX
Movements during the period
Recorded	8412
Acquisitions from third parties	8422
Cancelled	8432
Transferred from one heading to another	8442
Revaluation surpluses at the end of the period	8452
Amounts written down at the end of the period	8522P	XXXXXXXXXXXXXXXXXXXXX
Movements during the period
Recorded	8472
Written back	8482
Acquisitions from third parties	8492
Cancelled owing to sales and disposals	8502
Transferred from one heading to another	8512	··············································································································································································
Amounts written down at the end of the period	8522
Uncalled amounts at the end of the period	8552P	XXXXXXXXXXXXXXXXXXXX
Movements during the period	8542
Uncalled amounts at the end of the period	8552
NET BOOK VALUE AT THE END OF THE PERIOD	(282)	15.126.591
ENTERPRISES LINKED BY A PARTICIPATING INTEREST - AMOUNTS RECEIVABLE
NET BOOK VALUE AT THE END OF THE PERIOD		XXXXXXXXXXXXXXXXXXXX
Movements during the period
Additions
Repayments
Amounts written down
Amounts written back
Exchange differences	8622
Other movements	8632
NET BOOK VALUE AT THE END OF THE PERIOD

ACCUMULATED AMOUNTS WRITTEN OFF AMOUNTS RECEIVABLE AT END OF THE PERIOD ………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………	8652

	Codes	Period	Preceding period
OTHER ENTERPRISES - PARTICIPATING INTERESTS AND SHARES
Acquisition value at the end of the period	8393P	XXXXXXXXXXXXXXXXXXXX	198.509
Movements during the period
Acquisitions	8363
Sales and disposals	8373	144.709
Transfers from one heading to another	8383
Acquisition value at the end of the period	8393	53.800
Revaluation surpluses at the end of the period	8453P	XXXXXXXXXXXXXXXXXXXX
Movements during the period
Recorded	8413
Acquisitions from third parties	8423
Cancelled	8433
Transferred from one heading to another	8443
Revaluation surpluses at the end of the period	8453
Amounts written down at the end of the period	8523P	XXXXXXXXXXXXXXXXXXXXX
Movements during the period
Recorded	8473
Written back	8483
Acquisitions from third parties	8493
Cancelled owing to sales and disposals	8503
Transferred from one heading to another	8513
Amounts written down at the end of the period	8523
Uncalled amounts at the end of the period	8553P	XXXXXXXXXXXXXXXXXXXXX	2.015
Movements during the period	8543
Uncalled amounts at the end of the period	8553	2.015
NET BOOK VALUE AT THE END OF THE PERIOD	(284)	51.785
OTHERS ENTERPRISES - AMOUNTS RECEIVABLE
NET BOOK VALUE AT THE END OF THE PERIOD	285/8P	XXXXXXXXXXXXXXXXXXX
Movements during the period
Additions
Repayments
Amounts written down
Amounts written back
Exchange differences
Other movements	8633 -
NET BOOK VALUE AT THE END OF THE PERIOD
ACCUMULATED AMOUNTS WRITTEN OFF AMOUNTS RECEIVABLE AT END OF
THE PERIOD	8653

Nr.

First - F2016 - 21 / 71

F 6.4.3

PARTICIPATING INTERESTS INFORMATION

Participating interests and shares in other enterprises

List of the enterprises in which the enterprise holds a participating interest, (recorded in heading 280 and the other enterprises in which the enterprise holds rights (recorded in headings 204 and 51/53 of assets) for an amount of at least 10 % of the capital issued.

	Rights held			Data extracted from the most recent annual accounts
NAME, full address of the REGISTERED OFFICE and for an enterprise governed by Belgian law, the COMPANY IDENTIFICATION NUMBER		directly		subsidiari es	Annual	Curre	Capita land reserves	Net result
	Nature	Number	0/0	0/0	accounts as per	ncy code	(+) or (-) (in units)
UCB Pharma SA BE 0403.096.168 Public limited company Allee de la Recherche 60 1070 Anderlecht Belgium					31/12/2016	EUR	2.613.507.445	92.240.429
Ordinary shares - IFRS figures 111.643.959			100,0	0,0
UCB Australia Pty. LTD Foreign company Level 1, 1155 Malvern Road (PO Box 158)
Australia					31/12/2016	AUD	24.343.697	1.343.701
Ordinary shares - IFRS figures 17.900.000			100,0	0,0
	Preferred shares	300.000	100,0	0,0
Redeemable Preference Shares		4.800.000	100,0	0,0
UCB Finance NV Foreign company Lage Mosten, 33 4822 NK BREDA Netherlands					31/12/2016	EUR	1.478.722.600	104.655.825
Ordinary shares - IFRS figures		538.459	100,0	0,0
Vedim Pharma SA Foreign company Paseo de la Castellana 141 Madrid 28046 Spain					31/12/2016	EUR	111.201.031	15.810.824
Ordinary shares - IFRS figures		1.235.167	100,0	0,0
UCB Japan Co LTD Foreign company Shinjuku Grand Tower, 8-17-1 Nishi-Shinjuku Shinjuku-ku, 160-0023, Tokyo Japan					31/12/2016	JPY	4.965.563.071	617.086.749
Ordinary shares - IFRS figures		69.980	100,0	0,0
UCB (Investments) LTD Foreign company Bath Road 208 SLOUGH, SL1 3WE Berkshire United Kingdom Cumulative Preference Shares - IFRS figures 44.928.426			100,0	0,0	31/12/2016	GBP	988.696.551	452.801.718

F 6.5.1

PARTICIPATING INTERESTS AND SHARES IN OTHER ENTERPRISES (CONTINUED)

	Rights held				Data extracted from the most recent annual accounts
NAME, full address of the REGISTERED OFFICE and for an enterprise governed by Belgian law, the COMPANY IDENTIFICATION NUMBER	directly		subsidiari ર્દિક		Annual	Curre	Capita land reserves	Net result
	Nature	Number	0/0	0/0	accounts as per	ncy code	(+) or (-) (in units)



	Ordinary Shares	1.000.100	100,0	0,0
UCB DE MEXICO S.A. de C.V. Foreign company Homero, 440 7° Floor
Col. Chapultepec Morales, 11570 MEXICO D.F. Mexico					31/12/2016	MXN	100.426.013	28.430.411
Ordinary shares - IFRS figures 51.449.999			100,0	0,0
UCB Pharma France SA Foreign company
rue Estienne d'Orves 420 F 92700 COLOMBES France					31/12/2016	EUR	106.484.858	6.069.881
Ordinary shares - IFRS figures		512.597	92,94	7,06
UCB Pharma S.P.A. (Italy) Foreign company Via Varesina 162
Italy					31/12/2016	EUR	56.721.058	11.364.550
Ordinary shares - IFRS figures		474.525	99,9	0,1
UCB A.E. (Greece) Foreign company 63, Agiou Dimitriou Street 17456 Alimos, Athens Greece					31/12/2016	EUR	7.784.368	1.070.702
Ordinary shares - IFRS Figures		368.013	99,85	0,15
UCB (Pharma) Ireland LTD Foreign company Unit Drug House, Magna Drive Magna Business Park, DUBLIN 24 Ireland					31/12/2016	EUR	2.739.638	106.698
Ordinary shares - IFRS figures		59.999	100,0	0,0
UCB Korea Co LTD Foreign company 5th Fl. Grace Tower, 127, Teheran-ro Seoul 135-911 Republic of Korea					31/12/2016	KRW	8.326.219.289	1.319.565.185
Ordinary shares - IFRS figures		138.666	100,0	0,0
UCB Farma Brasil LTDA Foreign company Sete de Setembro 67, sala 301 2005005 Rio de Janeiro Brazil					31/12/2016	BRL	419.206.462	-3.176.819
Ordinary shares - IFRS figures \$68.597.250			100,0	0,0

Nr.	BE 0403.053.608

PARTICIPATING INTERESTS AND SHARES IN OTHER ENTERPRISES (CONTINUED)

	Rights held				Data extracted from the most recent annual accounts
NAME, full address of the REGISTERED OFFICE and for an enterprise governed by Belgian law, the COMPANY IDENTIFICATION NUMBER		directly		subsidiari દિર	Annual	Curre	Capita land reserves	Net result
	Nature	Number	0/0	0/0	accounts as per	ncy code	(+) or (-) (in units)



UCB Pharmaceuticals (Taiwan) Ltd Foreign company Nanjing E. Road 287
China-Taiwan					31/12/2016	TWD	24.400.587	459.921
Ordinary shares - IFRS figures		1	100,0	0,0
UCB Trading (SG) Pte Ltd Foreign company Marina Boulevard 8 018981 Singapore Singapore					31/12/2016	SGD	258.449	18.911
Ordinary shares - IFRS figures		244.001	100,0	0,0
UCB Trading Malaysia Sdn Bhd Foreign company The Gardens South Tower Kuala Lumpur
Malaysia					31/12/2016	MYR	438.388	218.468
Ordinary shares - IFRS figures		400.000	100,0	0,0
UCB Trading (Thailand) Ltd. Foreign company Sathorn Square 98
Thailand					31/12/2016	THB	100.000.000	4
Ordinary shares - IFRS figures 19.999.998			100,0	0,0
UCB Trading (Shangai) CO LTD Foreign company Room 317, No. 439 Fu Te Xi Yi Road SHANGAI China					31/12/2016	CNY	8.396.456	11.618.022
Ordinary shares - IFRS figures		1	100,0	0,0
UCB Pharma A.S. (TURKEY) Foreign company
Palladium Tower, Barbaros Mah., Karbelen Sok 2
Gerçekler Sitesi B, kavacik/Beykoz, 34805 ISTANBUL Turkey					31/12/2016	TRY	38.418.295	20.343.554
Ordinary shares - IFRS figures		1.095.430	100,0	0,0
UCB India Private Ltd Foreign company 504, Peninsula Towers, Ganpatrao Kadam Marg, Lower Parel, 400013 MUMBAI India					31/12/2016	INR	718.372.036	23.397.246
Ordinary shares - IFRS figures		3.527	100,0	0,0

Nr.	BE 0403.053.608
-----	-----------------

F 6.5.1

PARTICIPATING INTERESTS AND SHARES IN OTHER ENTERPRISES (CONTINUED)

	Rights held				Data extracted from the most recent annual accounts
NAME, full address of the REGISTERED OFFICE and for an enterprise governed by Belgian law, the	directly		subsidiari es		Annual	Curre	Capita land reserves	Net result
COMPANY IDENTIFICATION NUMBER	Nature	Number	% %		accounts as per	ncy code	(+) or (-) (in units)



Uni-Mediflex Private Limited Foreign company
504, Peninsula Corporate Park Ganpatrao Kadam Marg 400013 Mumbay
India					31/12/2016	INR	7.832.091	0
Ordinary shares - IFRS figures		290.000	100,0	0,0
UCB S.R.O. Foreign company Thamova 13
18600 PRAHA 8 Czech Republic					31/12/2016	CZK	23.648.269	-7.784.183
Ordinary shares - IFRS figures 12.300.600			100,0	0,0
UCB GMBH Foreign company Alfred Nobelstrasse 10 D 40789 MONHEIM Germany					31/12/2016	EUR	244.255.232	180.784.669
Shares - IFRS figures		394.000	5,21	94,79
UCB HUNGARY LTD			্
Foreign company Obuda Gate Building, Arpad Fejelum utja 26-28, 1023 BUDAPEŠT Hungary					31/12/2016	HUF	432.390.158	165.172.195
		Shares - IFRS figures 148.000.000	100,0	0,0
UCB Pharma Sp. z.o.o. (Poland) Foreign company UI. Kruczkowskego 8
00-380 WARSAWA Poland					31/12/2016	PLN	72.872.177	13.809.509
Ordinary shares - IFRS figures		236.456	78,05	21,95
UCB Pharma LLC (Russia) Foreign company Shturvalnaya str. bldg1 5 Moscow 1253645
Russian Federation					31/12/2016	RUB	228.376.593	197.059.137
Ordinary shares - IFRS figures		1	100,0	0,0
UCB Bulgaria EOOD Foreign company Lyubata Str. Fl 4 Lozenetz, Sofia 1407
Bulgaria					31/12/2016	BGN	583.639	82.102
Ordinary shares - IFRS figures UCB Pharma Logistics LLC		500	100,0	0,0
Foreign company Shabolovka street 10 building 2

Moscow 119048 Russian Federation

Nr.	BE 0403.053.608
-----	-----------------

Participating Interests and Shares in other enterprises (continued)

	Rights held			Data extracted from the most recent annual accounts
NAME, full address of the REGISTERED OFFICE and for an enterprise governed by Belgian law, the		directly		subsidiari es	Annual	Curre ncy	Capita land reserves	Net result
COMPANY IDENTIFICATION NUMBER	Nature	Number	0%	%	accounts as per		(+) or (-) (in units)

Ordinary shares - IFRS figures UCB Ventures SA BE 0667.816.096 Public limited company Allée de la Recherche 60		1	100,0	0,0
1070 Anderlecht Belgium					31/12/2016	EUR	15.000.000	0
ordinary shares paid-up at 25% - IFRS figures 59.999.999 UCB Manufacturing Ireland Ltd. Foreign company Shannon Industrial Estate			100,0	0,0
Ireland					31/12/2016	EUR	179.499.000	-14.164.374
Classe A shares - IFRS figures		1.400.000	100,0	0,0
Deferred ordinary shares		800.000	100,0	0,0
Dermira INC Foreign company Middlefield Rd Menlo Park 275 94025 California United States Ordinary shares - IFRS figures		1.841.234	6,16	0,0	30/09/2016	USD	250.869.000	-25.510.000

Nr.
-----	--

BE 0403.053.608

OTHER INVESTMENTS AND DEPOSITS, ALLOCATION DEFERRED CHARGES AND ACCRUED INCOME

	Codes	Period	Preceding period
INVESTMENTS: OTHER INVESTMENTS AND DEPOSITS
Shares	51	7.784	7.784
Book value increased with the uncalled amount	8681	7.784	7.784
Uncalled amount	8682
Precious metals and artworks	8683		and the comments of the comments of
Fixed income securities	52
Fixed income securities issued by credit institutions		a marka masa mana mana masa mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara m
Fixed term accounts with credit institutions With residual term or notice of withdrawal
up to one month
between one month and one year
over one year
Other investments not mentioned above	8689	11.838.398	11.838.398

	Period
DEFERRED CHARGES AND ACCRUED INCOME
Allocation of heading 490/1 of assets if the amount is significant
Fair market value on bonds	217.638.876
Deferred Insurance - Circle Project	9.919.572
nterest receivable	4.305.608
Other expenses to be carried forward	384.941
Unrealized exchange differences	2.271.001

F 6.6

Nr. BE 0403.053.608

F 6.7.1 |

STATEMENT OF CAPITAL AND SHAREHOLDING STRUCTURE

	Codes	Period	Preceding period
STATEMENT OF CAPITAL
Social capital
Issued capital at the end of the period		XXXXXXXXXXXXXXXXXXXX	583.516.974
Issued capital at the end of the period		583.516.974

	Codes	Value	Number of shares
Changes during the period



Structure of the capital
Different categories of shares
Ordinary shares		583.516.974	194.505.658



Registered shares		XXXXXXXXXXXXXXXXXXX	68.104.491
Shares to bearer and/or dematerialized	8703	XXXXXXXXXXXXXXXXXX	126.401.167

	Codes	Uncalled amount	Capital called but not paid

Capital not paid
Uncalled capital	(101)	.	XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Called up capital, unpaid	8712	XXXXXXXXXXXXXXXXXX
Shareholders having yet to pay up in full
		.

・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・			.
……………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………

	Codes	Period
Own shares
Held by the company itselt
Amount of capital held		141.173.133
Corresponding number of shares		3.079.536
Held by the subsidiaries
Amount of capital held		157.078.323
Corresponding number of shares		2.748.826
Commitments to issue shares
Owing to the exercise of conversion rights
Amount of outstanding convertible loans
Amount of capital to be subscribed
Corresponding maximum number of shares to be issued
Owing to the exercise of subscription rights
Number of outstanding subscription rights
Amount of capital to be subscribed
Corresponding maximum number of shares to be issued
Authorized capital not issued	8751

Nr. BE 0403.053.608		F 6.7.1

	Codes	Period
Shares issued, non representing capital
Distribution
Number of shares
Number of voting rights attached thereto
Allocation by shareholder
Number of shares held by the company itself
Number of shares held by its subsidiaries

AF A 100 OFD

PROVISIONS FOR OTHER LIABILITIES AND CHARGES

	Period
ANALYSIS OF THE HEADING 163/5 OF LIABILITIES IF THE AMOUNT IS SIGNIFICANT
Stock awards provision	20.920.100
Stock options provision	24.737.183
Stock appreciation rights provision	1.646.159
・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・

Nr.	BE 040

03.053.608

F 6.9

STATEMENT OF AMOUNTS PAYABLE, ACCRUED CHARGES AND DEFERRED INCOME

	Codes	Period
BREAKDOWN OF AMOUNTS PAYABLE WITH AN ORIGINAL PERIOD TO MATURITY OF MORE THAN ONE
YEAR, ACCORDING TO THEIR RESIDUAL TERM

Current portion of amounts payable after more than one year falling due within one year	8801
Financial debts
Subordinated loans	8811
Unsubordinated debentures
Leasing and other similar obligations
Credit institutions	8841
Other loans	8851
Trade debts	8861
Suppliers	8871	.
Bills of exchange payable
Advance payments received on contract in progress		.
Other amounts payable	8901
Total current portion of amounts payable after more than one year falling due within one year
Amounts payable with a remaining term of more than one but not more than five years
Financial debts	8802	1.000.850.953
Subordinated loans	8812
Unsubordinated debentures		675.000.000
Leasing and other similar obligations
Credit institutions	8842
Other loans	8852	325.850.953
Trade debts	8862
Suppliers	8872
Bills of exchange payable
Advance payments received on contracts in progress
Other amounts payable	8902	.
Total amounts payable with a remaining term of more than one but not more than five years	8912	1.000.850.953

Amounts payable with a remaining term of more than five years
Financial debts	8803	525.717.000
Subordinated loans	8813	.
Unsubordinated debentures		525.717.000
Leasing and other similar obligations
Credit institutions
Other loans	8853
Trade debts	8863
Suppliers	8873
Bills of exchange payable	8883
Advance payments received on contracts in progress	8893
Other amounts payable	8903
Total amounts payable with a remaining term of more than five years	8913	525.717.000

	DE 0409 000 000

	Codes	Period
GUARANTEED AMOUNTS PAYABLE (included in headings 17 and 42/48 of the liabilities)
Amounts payable guaranteed by Belgian public authorities
Financial debts
Subordinated loans	8931
Unsubordinated debentures
Leasing and similar obligations
Credit institutions
Other loans
Trade debts
Suppliers		.
Bills of exchange payable
Advance payments received on contracts in progress
Remuneration and social security
Other amounts payable	9051
Total amounts payable guaranteed by Belgian public authorities	9061
Amounts payable guaranteed by real securities or irrevocably promised by the enterprise on its own assets
Financial debts	8922
Subordinated loans
Unsubordinated debentures	8942
Leasing and similar obligations
Credit institutions	8962
Other loans	8972
Trade debts	8982	.
Suppliers	8992
Bills of exchange payable	9002
Advance payments received on contracts in progress	9012
Taxes, remuneration and social security	9022
Taxes	9032	.
Remuneration and social security	9042
Other amounts payable	9052
Total amounts payable guaranteed by real securities or irrevocably promised by the enterprise ON Its OWN assets	9062

	Codes	Period
TAXES, REMUNERATION AND SOCIAL SECURITY
Taxes (heading 450/3 of the liabilities)
Outstanding tax debts
Accruing taxes payable		10.338.800
Estimated taxes payable		11.645
Remuneration and social security (heading 454/9 of the liabilities)
Amounts due to the National Social Security Office		.
Other amounts payable in respect of remuneration and social security		10.393.807

BE 0403.053.608	F 6.9
	Period
ACCRUALS AND DEFERRED INCOME
Allocation of heading 492/3 of liabilities if the amount is significant
Accrued interests	28.861.143
Stock options recharges	15.209.629
Other accrued charges	1.271.260
Unrealized exchange differences	31.183.770
Fair market value on bonds	13.003.201

Nr. BE 0403.053.608

OPERATING RESULTS

	Codes	Period	Preceding period
OPERATING INCOME
Net turnover
Allocation by categories of activity




Allocation into geographical markets




Other operating income Operating subsidies and compensatory amounts received from public authorities
OPERATING CHARGES
Employees for whom the entreprise submitted a DIMONA declaration or who are recorded in the general personnel register
Total number at the closing date	9086	142	144
Average number of employees calculated in full-time equivalents	9087	142,2	134,1
Number of actual worked hours	9088	230.140	217.256
Personnel costs
Remuneration and direct social benefits		29.074.549	20.130.168
Employers' contribution for social security	621	5.204.687	5.105.961
Employers' premiums for extra statutory insurance	622	5.942.308	4.144.788
Other personnel costs	623	37.138.984	46.830.466
Retirement and survivors' pensions	624	3.737	12.197

Nr. BE 0403.053.608			F 6.10
	Codes	Period	Preceding period
Provisions for pensions and other similar rights
Appropriations (uses and write-backs)	635	-458.402	-428.677
Amounts written off
Stocks and contracts in progress
Recorded
Written back	9111
Trade debts
Recorded	9112	4.772	2.847
Written back	9113		5.002
Provisions for liabilities and charges
Additions			5.997.572
Uses and write-backs	9116	8.131.607	428.677
Other operating charges
l axes related to operation		1.347.465	1.115.586
Other costs	641/8	812.786	488.448
Hired temporary staff and personnel placed at the enterprise's disposal
Total number at the closing date
Average number calculated in full-time equivalents		1,4	0.9
Number of actual worked hours	9098	2.662	1.767
Costs to the enterprise		73.987	46.178

Nr. BE 0403.053.608

FINANCIAL AND EXTRAORDINARY RESULTS

	Codes	Period	Preceding period
FINANCIAL RESULTS
Other financial income Subsidies granted by public authorities and recorded as income for the period
Capital subsidies
Interest subsidies			and the comments of the comments of the comments of the comments of the comments of the comments of the contribution of the contribution of the contribution of the contributi
Allocation of other financial income
Foreign exchange		83.635.567	39.024.537
Gains on disposal of equity securities		464.741	473.374
		.	and the same of the same of the same of the same of the same of
RECURRING FINANCIAL CHARGES
Depreciation of loan issue expenses and reimbursement premiums	6501	2.422.633	2.085.433
Capitalized Interests	6503 -
Amounts written off current assets
Recorded
Written back	6511
Other financial charges
Amount of the discount borne by the enterprise, as a result of negotiating amounts receivable	653
Provisions of a financial nature
Appropriations
Uses and write-backs
Allocation of other financial charges
Foreign exchange		83.988.273	41.553.148
Bank charges		237.485	152.498
Various bank charges		190.062	159.848

Nr.

F 6.12

INCOME AND COSTS OF EXCEPTIONNAL SIZE OR OF EXCEPTIONNAL OCCURENCE

	Codes	Period	Preceding period
NON-RECURRING INCOME	76	25.194.493
Non-Recurring Operating Income	(76A)
Write-back of depreciation and of amounts written off intangible and tangible fixed assets	760
Write-back of provisions for extraordinary operating liabilites and charges I	7620
Capital gains on disposal of intangible and tangible fixed assets	7630
Other non-recurring financial income	764/8		.
Non-recurring financial income	(76B)	25.194.493	.
Write-back of amounts written down financial fixed assets	761	25.194.493
Write-back of provisions for extraordinary financial liabilities and charges	7621
Capital gains on disposal of financial fixed assets	7631
Other non-recurring financial income	769
NON-RECURRING CHARGES	66	86.809.837	2.208.535
Non-recurring operating charges	(66A)	-627.000	627.000
Extraordinary depreciation of and extraordinary amounts written off formation expenses, intangible and tangible fixed assets	660
Provisions for extraordinary operating liabilities and charges: appropriations (uses)	6620	-627.000	627.000
Capital losses on disposal of intangible and tangible fixed assets	6630		1.082.734
Other non-recurring operating charges	664/7
Non-recurring operating charges carried to assets as restructuring costs .(-)	6690
Non-recurring financial charges	(66B)	87.436.837	1.581.535
Amounts written off financial fixed assets	661	87.436.837	498.801
Provisions for non-recurring financial liabilities and charges: appropriations (uses)	6621
Capital losses on disposal of financial fixed assets	6631
Other non-recurring financial charges	668
Non-recurring financial charges to assets as restructuring costs	6691

Nr.

BE 0403.053.608

INCOME TAXES AND OTHER TAXES

	Codes	Period
INCOME TAXES
Income taxes on the result of the period		1.118.998
Income taxes paid and withholding taxes due or paid		1.107.353
Excess of income tax prepayments and withholding taxes paid recorded under assets 9136
Estimated additional taxes	9137	11.645
Income taxes on the result of prior periods
Additional income taxes due or paid
Additional income taxes estimated or provided for
In so far as taxes of the period are materially affected by differences between the profit before taxes as stated in annual accounts and the estimated taxable profit
Loss on shares		87.436.837
Reversal of impairments on shares		-25.194.493
Foreign taxes		-1.107.353
Taxed provisions		-8.758.607
Dividend received deduction		-233.193.909
Disallowed expenses		19.194.169

	Period
Influence of the non-recurring results on the taxes

	Codes	Period
Status of deferred taxes
Deferred taxes representing assets		158.531.678
Accumulated tax losses deductible from future taxable profits
Deferred taxes representing liabilities
Allocation of deferred taxes representing liabilities

・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・

	Codes	Period	Preceding period
VALUE ADDED TAXES AND OTHER TAXES BORNE BY THIRD PARTIES
Value added taxes charged To the enterprise (deductible) By the enterprise		12.248.839 9.431.858	9.136.334 5.777.403
Amounts withheld on behalf of third party For payroll withholding taxes For withholding taxes on investment income	9148	12.099.976 27.970.001	13.890.343 27.724.660

F 6.13 |

RIGHTS AND COMMITMENTS NOT REFLECTED IN THE BALANCE SHEET

	Codes	Period
PERSONAL GUARANTEES PROVIDED OR IRREVOCABLY PROMISED BY THE ENTERPRISE AS SECURITY FOR DEBTS AND COMMITMENTS OF THIRD PARTIES ……………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………
Of which
Bills of exchange in circulation endorsed by the enterprise
Bills of exchange in circulation drawn or guaranteed by the enterprise - 9151
Maximum amount for which other debts or commitments of third parties are guaranteed by the
enterprise
REAL GUARANTEES
Real guarantees provided or irrevocably promised by the enterprise on its own assets as security of debts and commitments of the enterprise
Mortgages
Book value of the immovable properties mortgaged
Amount of registration		a marka mana mana mana mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara mara m
Pledging of goodwill - Amount of the registration
Pledging of other assets - Book value of other assets pledged		.
Guarantees provided on future assets - Amount of assets involved		.
Real guarantees provided or irrevocably promised by the enterprise on its own assets as security of debts and commitments of third parties
Mortgages
Book value of the immovable properties mortgaged
Amount of registration
Pledging of goodwill - Amount of the registration
Pledging of other assets - Book value of other assets pledged		.
Guarantees provided on future assets - Amount of assets involved	9202

F 6.14

BE 0403.053.608			F 6.14
		Codes	Period
OWN NAME BUT AT RISK TO AND FOR THE BENEFIT OF THE ENTERPRISE	GOODS AND VALUES, NOT DISCLOSED IN THE BALANCE SHEET, HELD BY THIRD PARTIES IN THEIR

	…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………
	………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………
SUBSTANTIAL COMMITMENTS TO ACQUIRE FIXED ASSETS
	www
	………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………
	……………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………
SUBSTANTIAL COMMITMENTS TO DISPOSE OF FIXED ASSETS
	……………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………
	……………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………
	…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………		.
FORWARD TRANSACTIONS
	Goods purchased (to be received)	9213
	Goods sold (to be delivered)	9214
	Currencies purchased (to be received)	9215	1.005.530.914
	Currencies sold (to be delivered)	9216	1.100.686.467

INI.		r 6.14
		Period

SERVICES	OBLIGATIONS COMING FROM TECHNICAL GUARANTEES CONNECTED WITH ALREADY PERFORMED SELLS OR





		Period
	AMOUNT, NATURE AND FORM OF THE IMPORTANT PENDING CASES AND OTHER IMPORTANT OBLIGATIONS

SETTLEMENT WITH REGARD TO THE COMPLEMENTARY RETREAT OR SURVIVAL PENSION FOR STAFF AND BOARD MEMBERS

・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・

Concise description

UCB SA has made regulations setting out an objective to be attained concerning the resources to be made available to retired salaried staff.

The objective decided upon is to be achieved by the payment to those retired, over and above the legal pension of : a) pensions or lump sums resulting from the maturity at the time of their retirement of group insurance policies, whose premiums have been paid by the person concerned throughout his career : b) possible pensions paid by the ASBL Fonds de Prévoyance UCB, a supplementary pension fund maintained from monthly

payments made by the company ;

c) a special sum, depending on the length of service, paid by the company on their retirement.

UCB SA has also subscribed to insurance policies in favor of the heirs of its salaried staff covering :

death benefit
temporary pensions to orphans.

These insurances are financed by the payment of annual premiums by the company. In addition, the company pays to a widow of a salaried staff employee, who dies in service, a special payment as an additional widow's pension.

Measures taken to cover the related costs

	Codes	Period
PENSIONS FUNDED BY THE ENTERPRISE
Estimated amount of the commitments resulting from past services 9220
Methods of estimation

	Period
ANDERE FINANCIËLE GEVOLGEN VAN MATERIËLE GEBEURTENISSEN DIE ZICH NA BALANSDATUM HEBBEN OORGEDAAN EN DIE NIET IN DE RESULTATENREKENING OF BALANS WORDEN WEERGEGEVEN

...................................

Nr.	BE 0403.053.608

		Period

BE 0403.053.608		F 6.14
		Period

	ENGAGEMENT TO BUY OR SELL THAT THE ENTREPRISE HAS AS A WRITER OF OPTIONS TO BUY OR SELL.
	Call options	64.731.668




		Period
	NATURE, COMMERCIAL PURPOSE AND FINANCIAL CONSEQUENCES OF THE SETTLEMENTS NOT INCLUDED IN
THE BALANCE
	If the risks and advantages that occur from such settlements are of any meaning and in the case that publishing such risks and advantages is necessary to judge the financial position of the company

	……………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………



		Period
CALCULATED)	OTHER RIGHTS AND ENGAGEMENTS NOT INCLUDED IN THE BALANCE (INCLUDING THOSE WHICH CANNOT BE



	��

Nr. BE 0403.053.608

F 6.15

RELATIONSHIPS WITH AFFILIATED ENTERPRISES AND ENTERPRISES LINKED BY PARTICIPATING INTERESTS

	Codes	Period	Preceding period
AFFILIATED ENTERPRISES
Financial fixed assets	(280/1)	4.767.452.752	7.711.460.994
Participating interests		4.767.452.752	7.711.460.994
Subordinated amounts receivable		··············································································································································································
Other amounts receivable	9281
Amounts receivable from affiliated enterprises		2.776.170.778	1.073.248.688
Over one year		2.144.980.001	1.048.711.945
Within one year		631.190.777	24.536.743
Current investments	9321
Shares		.
Amounts receivable	9341
Amounts payable		309.056.606	262.043.899
Over one year		.	.
Within one year		309.056.606	262.043.899
Personal and real guarantees
Provided or irrevocably promised by the enterprise as security for debts or
commitments of affiliated enterprises	9381 - 1	.
Provided or irrevocably promised by affiliated enterprises as security for
debts or commitments of the enterprise
Other significant financial commitments		.
Financial results
Income from financial fixed assets		248.763.548	250.617.521
Income from current assets		107.689.704	90.529.017
Other financial income		45.431.691	10.243.066
Debt charges		5.550.292	2.992.746
Other financial charges		39.323.681	7.492.628
Disposal of fixed assets
Capital gains obtained
Capital losses suffered		.

Nr. BE 0403.053.608			F 6.15
	Codes	Period	Preceding period
ASSOCIATED ENTERPRISES
Financial fixed assets	9253		.
Participations	9263
Subordinated amounts receivable	9273
Other amounts receivable	8283
Over one year	9293
Over one year	9303		.
Within one year	9313		.
Amounts payable	9353	.	.
Over one year	9363		.
Within one year	9373
Personal and real guarantees Provided or irrevocably promised by the enterprise as security for debts or commitments of associated enterprises Personal and real guarantees provided or irrevocably promised by associated enterprises as security for debts or commitments of the	9383		.
enterprise	9393
Other significant financial commitments	9403
ENTERPRISES LINKED BY PARTICIPATING INTERESTS
Other enterprises linked by participating interests	9252	15.126.591	15.126.591
Participating interests	9262	15.126.591	15.126.591
Subordinated amounts receivable	9272
Other amounts receivable	9282		.
Amounts receivable	9292
Over one year	9302		.
Within one year	9312		.
Amounts payable	9352
Over one year	9362
Within one year	9372	.

RANSACTIONS WITH ENTERPRISES LINKED BY PARTICIPATING INTERESTS OUT OF MARKET CONDITIONS Mention of these transactions if they are significant, including the transactions, the nature of the link, and all information about the transactions which should be necessary to get a better understanding of the situation of the company
NONE

Period 0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

APA

FINANCIAL RELATIONSHIPS WITH

DIRECTORS, MANAGERS, INDIVIDUALS OR BODIES CORPORATE WHO CONTROL THE ENTERPRISE WITHOUT BEING ASSOCIATED THEREWITH OR OTHER ENTERPRISES CONTROLLED BY THESE PERSONS

	Codes	Period
Amounts receivable from these persons		.
Most important conditions on amounts receivable, rate of interest, duration, amounts possibly refunded, cancelled or written out

Guarantees provided in their favour
Other significant commitments undertaken in their favour
Amount of direct and indirect remunerations and pensions, included in the income statement, as long as this disclosure does not concern exclusively or mainly, the situation of a single identifiable person
To directors and managers		and and the comments of the comments of
To former directors and former managers

Auditors or people they are linked to

	Codes	Period
Auditor's fees	8505	417.750
Fees for exceptional services or special missions executed in the company by the auditor
Other attestation missions		46.700
Tax consultancy		and the same of the same of the states of the states of the states of the states of the states of the states of the states of the states of the states of the states of the st
Other missions external to the audit		130.074
Fees for exceptional services or special missions executed in the company by people they are linked to
Other attestation missions
Tax consultancy	95082	、
Other missions external to the audit		130.839

Mentions related to article 133, paragraph 6 from the Companies Code

Nr.	BE 0403.053.608

F 6.17 |

DERIVATIVES NOT MEASURED AT FAIR VALUE

VOOR IEDERE CATEGORIE AFGELEIDE FINANCIËLE INSTRUMENTEN DIE NIET GEWAARDEERD ZIJN OP BASIS VAN REËLE WAARDE

Category derivative fincial instruments	Hedged risk	Speculation / hedging	Scope	Period: Booked value	Period: Real value	Preceding period: Booked value	Preceding period: Real value
Plain vanilla - FX derivatives (fair value = accrued intrests)	FX risks	Hedging	1.132.702.107	-28.912.769	-28.912.769	0	189.968

	Booked value	Real value
FINANCIAL FIXED ASSETS BOOKED AT A HIGHER AMOUNT THAN THE REAL VALUE Amount of the seperate assets or fit groups

Reasons why the book value is not diminished

Elements that allow to suppose that the book value will be realised

Nr. BE 0403.053.608
------------------------

INFORMATION RELATING TO CONSOLIDATED ACCOUNTS

INFORMATION TO DISCLOSE BY EACH ENTERPRISE THAT IS SUBJECT TO COMPANY LAW ON THE CONSOLIDATED ACCOUNTS OF ENTERPRISES

The enterprise has prepared and published consolidated accounts and a consolidated report

VALUATION RULES

SUMMARY OF VALUATION RULES .

I. Formation expenses.

Formation expenses, which are not taken account of in the profit and loss account of the year, in which they are incurred, are depreciated over a maximum period of five year.

II. Intangible fixed assets.

R & D costs have been transferred to intangible fixed assets at their purchase or cost price. In order to make results of the previous years comparable, R & D costs capitalized have been wholly depreciated as a charge against current profits but the difference between the actual amount of depreciation taken in the year and the gross amount capitalized has a write-back of depreciation in the exceptional profits.

Since 1984, a depreciation rate has been applied to these costs not exceeding that of reducing depreciation based on a life of four years, being in practice 50 % in the first year and 25 % in the second and third years.

From 1990, a straight line depreciation rate of 33,33 % has been applied to these costs, based on a three year life considering "prorata temporis".

The purchase price of patents, licenses and similar items has been depreciated at a minimum rate equal to that of the assets required to handle the patent or process and otherwise over three years by the straight line method.

From 1990, the purchase price of patents, licenses and similar items has been depreciated over a fixed number of years, whose number cannot be less than five, equivalent to 20 % per annum considering "prorata temporis".

The purchase price of patents, licenses and similar items can also be depreciated in function of a prudent appreciation on the duration of the economic life of this intangible asset.

The purchase or cost price of intangible fixed assets, other than those referred to above, and which are eligible for subsidies (costs of commercial studies, of organizations, etc.) have been wholly depreciated in the year in which these expenses were incurred.

Intanqible fixed assets, whose depreciation is taken over a period of five years or less, are removed from the balance sheet along with the relevant depreciation during the fifth year following their inclusion in assets.

Software acquired which is not essential for the functioning of the computer system and of a value above 1.250 Euro has been treated as an intangible fixed assets and "prorata temporis" depreciated over five years on a straight line basis.

Intangible fixed assets, whose depreciation is taken over a period of five years or less, are removed from the balance sheet along with the relevant "prorata temporis" depreciation during the fifth year following their inclusion in assets.

Since 2003, costs of new acquisitions haven been depreciated on a "prorata temporis" basis.

III. Tangible fixed assets.

Fixed assets purchased from third parties have been included in the assets on the balance sheet at their purchase price ; assets manufactured by the company itself have been valued at their cost price.

The purchase or cost price has been depreciated on a straight line basis considering "prorata temporis" at the usual rates agreed by the tax authorities which prevent overvaluation of the net value of fixed assets.

These annual rates of depreciation are as follows : 3 % Buildings, houses Administrative buildings 3 % F 6.19 |

7		BE 0403.053.608
---	--	-----------------

Industrial buildings
Tools		15 %
Furniture and office equipment		15 %
Vehicles		20 %
Computer equipment and office machinery	33 1/3 %
Prototype equipment	33 1/3 %

Assets in the course of construction at the rate of the item and provided for to which they will be transferred In specific economical circumstances, write-off can be increased.

Tangible fixed assets sold to third parties have been written off at their gross value. At the same time the depreciation already taken in the previous year has been written back. The difference between the amount realized and the residual values gives rise to a surplus or deficit, which has been taken in exceptional profits and losses.

Fixed assets taken out of use have followed the same procedure. The residual value has been depreciated in total and taken against exceptional profits.

In the case of the transfer (by sale or contribution) of a branch of activity or of a division, the depreciation relating to the tangible fixed assets thus transferred during the year has been calculated pro rata temporis to the holding in the company.

Reciprocally, the rule of pro rata temporis has been applied to those tangible fixed assets entering into the balance sheet of the company following the acquisition during the year of a branch of activity or of a division.

Software acquired essential for the functioning of the computer system has been treated as tangible fixed assets and has been depreciated in accordance with the rules in force for computer equipment, being 33 1/3 % per annum.

IV. Financial fixed assets.

Shareholdings have been valued individually each year by the Board of Directors on the basis of their valuation on the stock exchange, their realizable value, their income and their potential interest for the future of the UCB Group.

Reductions in value, which have resulted, have been taken against exceptional profits and losses.

v. Stocks .

Bought-in items, both raw materials and supplies, have been valued at cost price or at market price, if the latter is lower. The purchase price includes the value of the purchases increased by import duties or excise taxes, transport costs and taxes not recoverable and, where appropriate, unloading costs.

Write-offs are made annually on slow moving spares in order to achieve on a cumulative basis the same percentage write-off as depreciation on the corresponding tangible fixed assets. The annual charge may, however, not exceed 10 % of the value of the stock of these items at the year.

Work in progress and finished goods have been valued at industrial cost, that is excluding general charges (other than factory overheads), depreciation and financial charges. This value has been reduced to likely selling prices, less related sales costs, if these are lower.

Marketable goods have been valued at their cost price or at market price at the end of the year, if the latter is lower. The purchase price of major raw materials and consumable stores, including those incorporated in work in progress and finished goods,

has been fixed in accordance with the LIFO method. The purchase price of other stocks has been fixed in accordance with the FIFO method.

VI. Receivables and liabilities.

Have been entered on the balance sheet at their nominal value. Receivables have been written down if their repayment, when due, is wholly or partly uncertain or

F 6.19

Nr.	BE 0403.053.608

doubtful.

VII. Foreign currencies.

A. Foreign currency transactions

Non-monetary assets (and liabilities), such as inventories, real estate, participations, which have resulted in a foreign currency transaction, are and are recorded in the accounts at their acquisition value in EURO as Conversion of the amount in foreign currency at the exchange rate, adopted on the day on which the transaction was reqistered ("historical" price).

This rule also applies as regards the recording, in EURO, of claims and monetary debts denominated in foreign currency. At the end of the financial year, the countervalue in EURO of these items is remeasured on the basis of the average market price on the closing date of the accounts.

The translation differences, both positive, resulting from these re-estimates are taken directly into account.

B. Fair value hedges : FX risks

Depending on the nature of the financial instrument and the presence of the underlying on the balance sheet, the impact of derivatives has been recognized directly in the income statement in accordance with IFRS (International Financial Reporting Standards) Balance sheet according to Belgian standards.

Since January 1, 2016, UCB SA has made a change in accounting rules in these statutory accounts in order to align the two accounting standards. The derivative products are now recognized directly in the profit and loss accounts in BEGAAP standards.

The Board approved this change in accounting rules to facilitate the closing process and align the statutory valuation rules under the BBGAAP standards with the Group's accounting policies under International Financial Reporting Standards (IFRS) and thus facilitating comparison with IRRS.

The impact of this change in accounting for the financial year 2016 generated a negative result of € 28 million included in financial results.

Without this change in accounting, the financial statements would have been presented as follows:

Fixed assets	4.806.208.564 €
Current assets	3.193.357.966 €
Total assets	7.999.566.531 €

Equity 5.765.562.976 € Debts and provisions 2.234.003.555 €

Total liabilities 7.999.566.531 €

C. Fair value hedges : interest rate risk

In case an IRS is concluded under the form of a fair value hedge, the interests to be paid for the loan will be offset by the interests to be received from the IRS in the entity where the loan is accounted for. However the changes in fair value of the derivative will not be offset with the changes in fair value of the loan will remain accounted for at amortised cost under Bgaap. Therefore, as there is no offsetting exposure for the changes in fair value of the derivative, the derivative will only be accounted for as an off-balance sheet commitment and the changes in fair value will not affect profit and loss accounts. This is in line with the guidance in advice 2011/18 issued by the Belgian Accounting Commission (see § III D. of the advice) which

F 6.19

DE ALOO OFO COO DC 0403.003.000

states that, in case an IRS is concluded as a hedging operation (as opposed to a speculative operation), the eventual (negative) fluctuation in market value of the IRS does not need to be taken in profit and loss since the change in market value of the loan does not need to be accounted for neither.

In case of a CCIRS (cross currency interest rate swap), the same rules will apply except for the foreign currency part of the derivative. In this particular case, the fluctuations in fair value of the CCIRS that are due to the forex component do have an offsetting exposure as the outstanding loan will be in foreign currencies which is revalued through profit and loss. In this case, the forex component of the derivative will be measured at fair value on the balance sheet and all fluctuations of this component will go through P&L. The interest rate component of the derivative will only be accounted for as an off-balance sheet commitment and disclosed in the notes to the financial statements. This is in line with advice 2011/18 issued by the Belgian Accounting Commission (see § III D. of the advice) as the change in fair value of the forex component will be accounted for in profit and loss due to the current valuation rules whereby all revaluation effects of monetary assets and liabilities are accounted for through P&L.

D. Cash flow hedge : FX risks

The effects of changes in fair value of cash flow hedges will only be accounted for as an offbalance sheet commitment and disclosed in the notes. In case of a back-to-back cash flow hedge for FX risk concluded by the Treasury Center, the cash flow hedge will have an offsetting exposure; so in this case, the cash flow hedge will be accounted for at fair value in the balance sheet with fluctuations going through P&L.

In case the FX risk would be hedged by options, the same methodology as explained above will be followed. In case of hedging a forecasted transaction with options, the hedged transaction is not on the balance sheet yet and since there is no offsetting exposure for the derivative, the derivative will be accounted for as an off-balance sheet commitment and disclosed in the notes to the statutory financial statements.

In order to further align the Bgaap accounting treatment of hedged transactions with the IFRS accounting treatment, UCB also proposes to recognize the effective portion of changes in the fair value of derivative financial instruments that are designated and qualify as cash flow hedges, on the same line in the income statement as the hedged item (firm commitment/forecasted transaction) at the moment the hedged item affects profit or loss or on the same line in the balance sheet at the moment the hedged forecasted transaction results in the recognition of a non-financial asset or liability (as part of the initial measurement of that asset or liability). UCB proposes to use the same average rate methodology as adopted under IFRS for recognition of the effective portion of changes in the fair value of derivative financial instruments into P&L.

E. Cash flow hedge : interest rate risks

In case of an IRS accounted for as a cash flow hedge, the same accounting principles will apply as mentioned above under IRS concluded as fair value hedges. As there is no offsetting exposure for the changes in fair value of the derivative, the derivative will only be accounted for as an offbalance sheet commitment and the changes in fair value will not affect profit and loss accounts. This is also applicable in case an IRS is concluded for a forecasted transaction. This is in line with § III C. (IRS as hedging for a loan with variable interest rate) and E. (IRS as hedging for a forecasted transaction) of the advice 2011/18 issued by the Belgian Accounting Commission.

As a result, the Bgaap accounting treatment of cash flow hedges that hedge the interest rate risk will be different from the IPRS accounting. Under IFRS the effects of changes in fair value of cash flow hedges will be accounted for in equity whereas under Bgaap these will only be accounted for as an off-balance sheet commitment and disclosed in the notes.

F. Net investment hedge

The net investment hedge will be accounted for as an off-balance sheet commitment and disclosed in

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ . A A A A Same Same " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " "

the notes to its statutory financial statements except in case there would be an offsetting exposure. The Bgaap accounting of net investment hedges will be different from the IFRS accounting.

Under IFRS any impacts of net investment hedges are accounted for in equity. Under Bgaap these will be accounted for as an off-balance sheet commitment and disclosed in the notes to the financial statements unless there is an offsetting exposure in which case the hedge is accounted for at fair value on the balance sheet with fluctuations going through P&L.

VIII. Accounting treatment of fair value adjustments on loans being acquired

UCB amended the accounting treatment of fair value adjustments on loans being acquired under the Belgian Generally Accepted Accounting Principles (BEGAAP), applicable to the 2016 full year accounts, as follows: UCB SA/NV will recognize the intercompany loans that are transferred from UCB Lux S.A. at nominal value and will recognize the differences between the acquisition value (= fair value) and the nominal value of these loans on an accrual account.

As a result of this change, a fair market value of € 207 million has been recognized as a deferred charge on the balance sheet and will be taken in income statement pro rata temporis on a linear basis over the remaining duration of the loans. The total net result for accounting year 2016 has been negatively affected by an amount of € 3 million instead of € 207 million in case of immediate recognition in the income statement (as per the old accounting rules).

The new accounting treatments are in the best interest of the Company and are in accordance with applicable laws and regulations.

IX. Provisions for risk and charges.

All risks affecting the company, have been the subject of provision which are re-assessed each year, following the rules of prudence, good faith and sincerity.

RIGHTS AND COMMITMENTS NOT INCLUDED IN THE BALANCE SHEET.

DESCRIPTION OF THE SUPPLEMENTARY SCHEME FOR RETIREMENT AND SURVIVING DEPENDANTS PENSIONS.

I. Supplementary scheme for retirement pensions.

UCB SA has made regulations setting out an objective to be attained concerning the resources to be made available to retired salaried staff.

The objective decided upon is to be achieved by the payment to those retired, over and above the legal pension of :

a) pensions or lump sums resulting from the maturity at their retirement of group insurance policies,

whose premiums have been paid by the person concerned throughout his career ; b) possible pensions paid by the ASBL Fonds de Prévoyance UCB, a supplementary pension fund maintained from monthly payments made by the company ;

c) a special sum, depending on the length of service, paid by the company on their retirement.

II. Supplementary scheme for pensions to surviving dependants.

UCB SA has also subscribed to insurance policies in favor of the heirs of its salaried staff covering :

death benefit
temporary pensions to orphans.

AF A LOO AEA AA C

III. Other Benefits.

UCB SA has made internal regulations providing income to employees absent through accident, sickness, maternity, etc., for periods which vary according to their length of service.

1.4 Settlement of outstanding Belgian commercial paper ("BCP") position

During 2016, the UCB Group pursued its strategy to reduce its global debt exposure. As a result, UCB SA/NV reimbursed the total amount of the outstanding Belgian commercial paper position for a total amount of € 104 million.

1.5 Transfer of obligations under 2016 Performance Share Plan from UCB SA/NV to UCB Fipar SA/NV

Similar to 2014 and 2015, the obligations of UCB SA/NV under the 2016 UCB Performance Share Plan have been transferred to UCB Fipar SA/NV. UCB Fipar SA/NV has received a compensation of € 11 million for assuming this plan.

1.6 Transfer of treasury operations

During the last quarter of 2016, the UCB Group aimed to centralize the treasury team and operations in Belgium in order to allow for synergies within, and to optimize the operational efficiency of the UCB treasury function.

Those treasury activities were managed partly in Luxembourg within UCB Lux S.A. until November 2016, and the centralization involved the following steps, as further described below:

a) the acquisition of the participations owned by UCB Lux S.A. in certain UCB affiliates by UCB SA/NV:
b) the assignment of intra-group receivables from UCB Lux S.A. partly to UCB SA/NV and partly to UCB Biopharma SPRL/BVBA;
c) the assignment of loans from the European Investment Bank ("EIB") to UCB SA/NV;
d) the early repayment of all outstanding loan agreements between UCB SA/NV and UCB Lux S.A.; and
e) the liquidation of UCB Lux S.A. following these transfers.

Acquisition of UCB affiliates owned by UCB Lux S.A.

On 7 November 2016, UCB SA/NV completed the share purchase agreements of several affiliates owned by UCB Lux S.A (or its affiliate Celltech Group Ltd.). The purchase price has been determined based on the fair value of the affiliates. The concerned affiliates are listed below:

· UCB (Investments) Ltd. shares acquired from UCB Lux S.A. for a total amount of € 1 110million;
UCB Australia Pty. Ltd. shares acquired from Celltech Group Ltd. for a total amount of € 29 million;
UCB Pharma S.p.A. (Italy) shares acquired from UCB Belgium SA/NV, UCB Finance N.V., UCB FIPAR SA/NV and Celltech Group Ltd. for a total amount of € 107 million; and

F 8

· UCB Pharma A.S. (Turkey) shares acquired from UCB Lux S.A. for a total amount of € 19 million.

Assignment of intra-group receivables

On 10 November 2016, UCB SA/NV concluded an agreement with UCB Lux S.A. in order to assign the receivables from various related parties from UCB Lux S.A. to UCB SA/NV. In return for the assignment UCB SA/NV paid a total consideration of € 2 964 million, based on an at arm's length valuation of these receivables.

The total nominal value of the assigned receivables amounts to € 2 731 million and concerns the following loan agreements:

· £ 200 million loan contracted with UCB Celltech (UK Branch of UCB Pharma SA/NV) maturing September 2018;
£ 650 million loan contracted with UCB Celltech (UK Branch of UCB Pharma SA/NV) maturing December 2018;
· € 615 million loan contracted with UCB Celltech (UK Branch of UCB Pharma SA/NV) maturing December 2018; and
· € 1 150 million loan contracted with UCB Biopharma SPRL/BVBA maturing June 2026.

The remaining difference of € 234 million between the nominal value and fair value of these loans is partially allocated to accrued interests for a total amount of € 27 million and partially as premium paid on the acquisition for a total amount of € 207 million. The premium is initially recognised as deferred charges on the balance sheet and deferred over the remaining duration of the loans concerned, hence in 2016 a financial expense has been recognized for a total amount of € 3 million, covering the period from the date of contribution until 31 December 2016.

Assignment of loans from the European Investment Bank ("EIB")

On 24 October and 21 November 2016, the respective interest reset dates of the concerned loans, UCB Lux S.A. assigned 2 loans with the European Investment Bank to UCB SA/NV, for a total value of € 100 million for the loan maturing April 2020 and a total value of € 150 million for the loan maturing May 2019.

Early repayment of loan agreements between UCB SA/NV and UCB Lux S.A.

On 7 November 2016, UCB SA/NV and UCB Lux S.A. confirmed that they mutually agreed to early reimburse all outstanding loan agreements between UCB SA/NV and UCB Lux S.A.

UCB Lux S.A. early repaid UCB SA/NV for a total amount of € 1 126 million representing the nominal amount of the loans for a total amount of € 1 040 million, accrued interests for a total amount of € 40 million and break-up costs for a total amount of € 46 million. The break-up costs related to the early repayment are recognized as a financial income in the income statement of 2016.

In the framework of this mutual agreement, UCB SA/NV then early repaid UCB Lux S.A. for a total amount of € 235 million in relation to the loan agreement contracted on 16 March 2016. Considering the short term of this loan, almost no break-up costs, nor accrued interests, hence the total consideration paid almost fully represents the nominal amount of the loan.

Liquidation of UCB Lux S.A.

On 30 December 2016, UCB Lux S.A. has been liquidated and this resulted in liquidation proceeds distributed to UCB SA/NV for a total amount of € 4 489 million including € 4 258 million as reimbursement of the participating interest in UCB Lux S.A. The remainder of € 231 million is recognized as an income from financial assets in the income statement of 2016.

1.7 Transactions in Own Shares

During 2016, UCB SA/NV acquired 36 945 UCB shares and disposed 928 677 UCB shares.

As a result, on 31 December 2016, UCB SA/NV retained a total of 4 079 536 UCB securities representing, if exercised, 2.10% of the total number of UCB shares.

That holding of UCB securities consists of 3 079 536 shares and 1 000 000 assimilated financial instruments (outstanding options).

The 3 079 536 UCB shares represent 1.58% of the capital and a par value of € 9 million. The amount reported in the balance sheet under the section "own shares" represents € 141 million.

1.8 Redemption of senior unsecured bonds

In December 2009, UCB SA/NV completed an offering of € 500 million senior unsecured bonds, carrying a coupon of 5.75% and an effective interest rate of 5.8150% per annum, and aimed at institutional investors

On 10 December 2016, these bonds matured and have been redeemed for a total nominal value of € 500 million on 12 December 2016.

1.9 Incorporation of UCB Ventures SA/NV

On 15 December 2016, UCB SA/NV incorporated a new subsidiary, UCB Ventures SA/NV, which will be used for investments in promising companies looking for venture capital or in partnerships. UCB SA/NV subscribed 99.99% of the capital for a total amount of € 60 million, of which € 45 million is uncalled.

As a result, on 31 December 2016, the participation of UCB SA/NV in UCB Ventures SA/NV amounts to € 15 million.

1.10 Risk of impairment on the shares held by UCB SA/NV - Impairment test on participations

On 31 December 2016, an impairment testing has been performed on the shareholdings of UCB SA/NV. This test resulted in the recognition of impairment charges amounting to € 87 million, fully related to its subsidiary UCB Biopharma SA in Brazil.

The impairment testing also revealed that some historical impairment charges were not relevant anymore. Hence those impairment charges have been reversed for a total amount of € 25 million:

· UCB Pharma Sp. z.o.o. for a total amount of € 4 million;
· UCB Korea Co. Ltd. for a total amount of € 2 million; and
UCB GmbH for a total amount of € 19 million.

Both the new impairment charges as well as the reversal of the historical impairment charges have been recognized in the financial results in the income statement of 2016.

2. Change in accounting policies

The Board of Directors of UCB SA/NV approved the following modifications to the valuation rules in relation to the accounting treatment of derivatives and fair value adjustments on loans being acquired.

Accounting treatment of derivatives

Under the Belgian Generally Accounting Principles (BEGAAP), there is no specific accounting guidance available relating to the accounting treatment of derivatives. Until now, all derivatives were not affecting the balance sheet and/or income statement accounts before maturing and were only disclosed as off-balance sheet commitments, which was not in line with the IFRS treatment (where hedge accounting is applicable).

Considering the above and in order to avoid mismatches between both BEGAAP and IFRS, UCB amended the accounting treatment of derivatives under the Belgian Generally Accepted Accounting Principles (BEGAAP), applicable to the 2016 full year accounts, as follows: UCB SA/NV will account for derivatives at fair value through P&L unless the derivative has no offsetting exposure in the standalone financial statements, in which case, the derivative will only be disclosed as off-balance sheet commitment not affecting the balance sheet and/or income statement accounts. The amount disclosed as off-balance sheet commitment will be in line with IFRS methodology (spot-to-spot for cash flow hedges, clean market value for IRS).

F 8

Additionally, UCB will classify the effective portion of changes in the fair value of derivative financial instruments that are designated and qualify as cash flow hedges, on the same line, in the income statement or balance sheet, as the hedged item once the hedged item affects profit or loss or results in the recognition of a non-financial asset or liability.

As a result of this change, the 2016 annual accounts of UCB SA/NV have been affected as following:

increase of the accrued income for a total amount of € 2 million;
· increase of the accrued charges for a total amount of € 31 million;
· net loss of € 29 million, presented in the income statement under other financial income for a total amount of € 2 million and other financial charges for a total amount of € 31 million.

Accounting treatment of fair value adjustments on loans being acquired

As a result of the transfer from the treasury operations from Luxembourg to Belgium, UCB has assigned some of its intercompany loans (receivables and payables) between UCB Lux S.A. and other UCB entities from UCB Lux S.A. to UCB SA/NV on 10 November 2016 (except those that were early repaid).

Considering the above, UCB amended the accounting treatment of fair value adjustments on loans being acquired under the Belgian Generally Accepted Accounting Principles (BEGAAP), applicable to the 2016 full year accounts, as follows: UCB SA/NV will recognize the intercompany loans that are transferred from UCB Lux S.A. at nominal value and will recognize the differences between the acquisition value (= fair value) and the nominal value of these loans on an accrual account.

The new accounting treatments are in the best interest of the Company and are in accordance with applicable laws and regulations.

It is further acknowledged that the impacts of these new rules will be disclosed in the notes to the statutory financial statements for the accounting year 2016 for publication by the National Bank of Belgium.

Nr.

Internal controls in place regarding the establishment of the annual accounts

The Audit Committee, on behalf of the Board of Directors of UCB SA/NV, assessed the adequacy and effectiveness of the internal control system in detecting fraud, irregularities or infringement of laws, rules and regulations or material control failures on a regular basis. Internal control mechanisms are further described in the UCB Group 2016 Annual Report.

4. Major events after the balance sheet date

No major events occurred after the balance sheet date.

5. Conflicts of interest met during the financial year

There were no transactions or contractual relationships in 2016 between UCB SA/NV and a member of the Board of Directors giving rise to conflicts of interest, except as reported in section 1.9 (Application of article 523 of the Belgian Companies Code) of the Corporate Governance Statement included in the UCB Group 2016 Annual Report.

6. Financial information

Results at 31 December 2016

The operations of UCB SA/NV generated in 2016 a net profit of € 161 million after tax compared to € 172 million in 2015.

The evolution in the net profit (decrease of € 11 million) is mainly due to:

· the decrease in dividends received from its subsidiaries for a total amount of € 233 million, mainly from UCB Finance N.V. (€ 100 million), UCB India Private Limited (€ 29 million) and UCB Lux S.A. (€ 100 million) fully compensated by the net liquidation proceeds of € 231 million from UCB Lux S.A. distributed to UCB SA/NV (please refer to section 1.6);
· the decrease in other operating income and services and other goods related to legal fees incurred in 2015 in the framework of the divestment of Kremers Urban Pharmaceuticals Inc.;
· the decrease in the provision, to cover risk of share price changes of long-term incentives granted to the Executive Committee and certain categories of employees, for a total amount of € 14 million mainly due to the drop in UCB share price;

Inspired by patients.
Driven by science. Driven by science.

· the one-off financial income amounting to € 46 million related to the early repayment of a loan agreement by UCB Lux S.A. (please refer to section 1.6);
· the net impairment charge on participations amounting to € 62 million (please refer to section 1.10); and
· the net financial loss for a total amount of € 29 million related to the recognition of derivatives in BEGAAP in 2016 (please refer to section 2).

Result appropriation

The total net profit of € 161 million is available for distribution. The Board of Directors proposes the following allocation:

distribution to the shareholders of a gross dividend of € 1.15 per share; and
· drawing on available reserves for € 60 million.

The Board of Directors thus propose to pay, against delivery of coupon no. 20, a gross dividend of € 1.15 per share (giving right to a dividend net of Belgian 30% withholding tax of € 0.805). The aggregate amount to be distributed to the shareholders may fluctuate depending on the number of UCB shares held by UCB SA/NV (own shares) and its direct subsidiaries on the dividend approval date, as the UCB shares held by UCB SA/NV (own shares) and its direct subsidiaries are not entitled to a dividend. Per 1 January 2017, 191 426 122 UCB shares are entitled to a dividend, representing a total distribution of € 2.20 million. The Board of Directors will communicate at the General Meeting the total number of UCB shares entitled to the 2016 dividend and will submit the aggregate amount to be distributed to the shareholders for approval. The annual accounts of 2016 will be adapted accordingly.

Subject to the approval of the proposed dividend distribution by the General Meeting, coupon no. 20 will be payable as from 3 May 2017 at KBC Bank NV/SA, Havenlaan 12 Avenue du Port, 1080 Brussels (Belgium).

In accordance with the law, we request you to grant discharge to the Directors and the Statutory Auditor for the performance of their duties during the financial year ended 31 December 2016.

Balance Sheet items at 31 December 2016

On the balance sheet of UCB SA/NV at 31 December 2016, the total assets and liabilities amount to € 8 002 million, as compared to € 9 164 million at 31 December 2015.

The variation on the balance sheet is mainly driven by:

• the capital increase in its subsidiary UCB Farma Brasil Ltda for a total amount of € 36 million (please refer to section 1.3);

Inspired by patients. Driven by science.

the increase of participating interests in affiliates as a result of the acquisition of UCB affiliates owned by UCB Lux S.A. for a total amount of € 1 265 million (please refer to section 1.6), the capital increase in UCB Pharma SA/NV for a total amount of € 235 million (please refer to section 1.2) and the incorporation of UCB Ventures SA/NV for a total amount of € 15 million (please refer to section 1.9);
the decrease of the initial investment in UCB Manufacturing Ireland Ltd. for a total amount of € 175 million (please refer to section 1.2);
· the decrease of participating interest in affiliates as a result of the liquidation of UCB Lux S.A. and the corresponding distribution of liquidation proceeds for a total amount of € 4 258 million (please refer to section 1.6) and the recognition of impairment charges for a total amount of € 62 million (please refer to section 1.10);
· the increase in the long term intercompany receivable position as a result of the assignment of intra-group receivables from UCB Lux S.A. for a total amount of € 2 115 million compensated by the early repayment by UCB Lux S.A. of loan agreements for a total amount of € 1 040 million (please refer to section 1.6);
the increase in the short term intercompany receivable position as a result of the assignment of intra-group receivables from UCB Lux S.A. for a total amount of € 615 million (please refer to section 1.6);
· the increase of the deferred charges as a result of the premium paid for the assignment of the intra-group receivables for a total amount of € 221 million. The premium will be deferred over the remaining duration of the loans concerned, hence in 2016 a total amount of € 4 million has been deferred (please refer to section 1.6);
the decrease in the provision, to cover risk of share price changes of long-term incentives granted to the Executive Committee and certain categories of employees, for a total amount of € 8 million mainly due to the drop in UCB share price;
the increase in the long term financial debt position for a total amount of € 250 million due to the assignment of the loans from the European Investment Bank ("EIB") from UCB Lux S.A. to UCB SA/NV (please refer to section 1.6). As of December 31, 2016 € 19 million is reclassified to short-term debt due to repayment in 2017;
· the settlement of the current portion of amounts payable after more than one year falling due within one year as a result of the early redemption of the perpetual bond for a total amount of € 300 million (please refer to section 1.1) and the redemption of senior unsecured bonds for a total amount of € 500 million (please refer to section 1.8);
· the decrease in the short term financial debt position due to the settlement of the final outstanding Belgian commercial paper position for a total amount of € 104 million (please refer to section 1.4):
· the increase of the deferred revenues as a result of the premium paid for the assignment of the intra-group receivables for a total amount of € 14 million. The premium will be deferred over the remaining duration of the loans concerned, hence in 2016 a total amount of € 1 million has been deferred (please refer to section 1.6); and

F 8

· the decrease of the deferred revenues for a total amount of € 5 million as a result of the deferral of the revenue, related to stock options granted in 2013, in line with the exercise of options in 2016. On 31 December 2016 the outstanding revenue to be deferred amounts to € 15 million.

7. Changes to the composition of the Board

Please refer to the Corporate Governance Statement in the UCB Group 2016 Annual Report for the changes in the Board composition in 2016 as well as the proposals for changes to the composition for 2017.

8. Financial instruments, risks of credit, risks of liquidity and risks of treasury

Please refer to the UCB Group 2016 Annual Report, Financial Report, Notes to the Consolidated Financial Statements, Point 4 "Financial Risks Management".

9. Change of control

Please refer to section 1.8.9 of the Corporate Governance Statement included in the UCB Group 2016 Annual Report for a complete overview of all agreements including change of control provisions approved in and/or prior to 2016.

10. Activities in the area of research and development

The activities of UCB SA/NV are holding activities. There are no research and development activities at the level of UCB SA/NV.

11. Branches of UCB SA/NV

UCB SA/NV has no branches.

12. Corporate Governance Statement

The Corporate Governance Statement (including the Remuneration Report) is included in the UCB Group 2016 Annual Report.

Brussels, 22 February 2017.

Jean-Christophe Tellier Chief Executive Officer and Director

Chairman of the Board

F 7

' Nr.	BE 0403.053.608
	SOCIAL BALANCE SHEET
	Number of joint industrial committee:		207

STATEMENT OF THE PERSONS EMPLOYED

EMPLOYEES FOR WHOM THE ENTREPRISE SUBMITTED A DIMONA DECLARATION OR WHO ARE RECORDED IN THE GENERAL PERSONNEL REGISTER

During the current period	Codes	Total	1. Men	2. Women
Average number of employees
Full-time		130,1	54,6	75,5
Part-time		14,9	2,3	12,6
Total in full-time equivalents		142,2	56,3	85,9
Number of hours actually worked
Full-time		210.608	88.600	122.008
Part-time		19.532	2.892	16.640
Total		230.140	91.492	138.648
Personnel costs
Full-time		70.794.935	29.782.493	41.012.442
Part-time	1022	6.565.594	972.133	5.593.461
Total		77.360.529	30.754.626	46.605.903
Advantages in addition to wages	1033

During the preceding period		Codes P. Total	1P. Men	2P. Women
Average number of employees in FTE		134,1	55.6	78.5
Number of hours actually worked	1013	217.256	89.732	127.524
Personnel costs		76.211.383	31.477.150	44.734.233
Advantages in addition to wages	1033		.

Nr.	BE 0403.053.608
-----	-----------------

EMPLOYEES FOR WHOM THE ENTREPRISE SUBMITTED A DIMONA DECLARATION OR WHO ARE RECORDED IN THE GENERAL PERSONNEL REGISTER (continued)

At the closing date of the period	Codes	Full-time	Part-time 2.	Total full-time equivalents
Number of employees	105	128	14	139,5
By nature of the employment contract
Contract for an indefinite period		117	14	128,5
Contract for a definite period	111	11		11,0
Contract for the execution of a specifically assigned work	112
Replacement contract	113
According to gender and study level
Men	120	51	2	52,6
primary education	1200
secondary education	1201
higher non-university education	1202	ਤੇ	1	3,8
university education	1203	48	1	48,8
Women	121	77	12	86.9
primary education	1210
secondary education	1211	3	3	5,5
higher non-university education	1212	5	7	10,8
university education	1213	રેત્વે	2	70,6
By professional category
Management staff		16		16,0
Employees	134	112	14	123,5
Workers	132
Others	133

HIRED TEMPORARY STAFF AND PERSONNEL PLACED AT THE ENTERPRISE'S DISPOSAL

During the period	Codes	1. Hired temporary staff
Average number of persons employed		1.4
Number of hours actually worked	151	2.662
Costs for the enterprise	152	73.987

F 10 |

BE 0403.053.608

Total full-time 1. Full-time 2. Part-time 3. Codes equivalents 29 29,0 205 .............................................................................................................................................................................. 20,0 210 20 9 9,0 211 212 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LIST OF PERSONNEL MOVEMENTS DURING THE PERIOD

ENTRIES
Number of employees for whom the entreprise submitted a DIMONA declaration or who have been recorded in the general personnel register during the financial year
By nature of employment contract
Contract for an indefinite period	1 210
Contract for a definite period	211
Contract for the execution of a specifically assigned work 212
Replacement contract	213

DEPARTURES	Codes	Full-time 1.	Total full-time equivalents
Number of employees whose contract-termination date has been entered in DIMONA declaration or in the general personnel register during the financial year	305	31	31,0
By nature of employment contract
Contract for an indefinite period		14	14.0
Contract for a definite period	311	17	17,0
Contract for the execution of a specifically assigned work	312
Replacement contract
By reason of termination of contract
Retirement	340	1	1,0
Unemployment with extra allowance from enterprise	341
Dismissal	342	8	8,0
Other reason	343	22	22,0
the number of persons who continue to render services to
the enterprise at least half-time on a self-employed basis	350

DEPARTURES

been entered in DIMONA declaration or in the general personnel register during the financial year 30
By nature of employment contract
Contract for an indefinite period
Contract for a definite period	3
Contract for the execution of a specifically assigned work 31
Replacement contract
By reason of termination of contract
Retirement	3
Unemployment with extra allowance from enterprise 34
Dismissal	3
Other reason
the number of persons who continue to render services to the enterprise at least half-time on a self-employed basis . 3s

First - F2016 - 70 / 71

F 10 |

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Nr

BE 0403.053.608

INFORMATION ON TRAINING PROVIDED TO EMPLOYEES DURING THE PERIOD

	Codes	Men	Codes	Women
Total of initiatives of formal professional training at the expense of the employer
Number of employees involved	5801	44	5811	78
Number of actual training hours	5802	137	5812	459
Net costs for the enterprise	5803	12.490	5813	23.730
of which gross costs directly linked to training	58031	7.590	58131	19.987
of which fees paid and paiments to collective funds	58032	4.900	58132	3.743
of which grants and other financial advantages received (to deduct)	58033		58133
Total of initiatives of less formal or informal professional training at the expense of the employer
Number of employees involved	5821		5831
Number of actual training hours	5822		5832
Net costs for the enterprise	5823		5833
Total of initiatives of initial professional training at the expense of the employer
Number of employees involved	5841	6	5851	9
Number of actual training hours	5842	5.360	5852	10.256
Net costs for the enterprise	5843	53.580	2853	101.905

F 10

AI assistant

UCB — Annual Report 2016

4017_rns_2017-03-24_ea31dbe4-bec0-44e8-809c-96c72bc86045.pdf

ANNUAL ACCOUNTS AND OTHER DOCUMENTS TO BE FILED UNDER BELGIAN COMPANY LAW

IDENTIFICATION DETAILS

LIST OF DIRECTORS, BUSINESS MANAGERS AND AUDITORS AND DECLARATION REGARDING A COMPLIMENTARY REVIEW OR CORRECTION ASSIGNMENT

LIST OF THE DIRECTORS, BUSINESS MANAGERS AND AUDITORS

DECLARATION REGARDING A COMPLIMENTARY REVIEW OR CORRECTION ASSIGNMENT

ANNUAL ACCOUNTS

BALANCE SHEET AFTER APPROPRIATION

INCOME STATEMENT

APPROPRIATION ACCOUNT

EXPLANATORY DISCLOSURES

STATEMENT OF FORMATION EXPENSES

STATEMENT OF TANGIBLE FIXED ASSETS

STATEMENT OF FINANCIAL FIXED ASSETS

PARTICIPATING INTERESTS INFORMATION

Participating interests and shares in other enterprises

PARTICIPATING INTERESTS AND SHARES IN OTHER ENTERPRISES (CONTINUED)

PARTICIPATING INTERESTS AND SHARES IN OTHER ENTERPRISES (CONTINUED)

PARTICIPATING INTERESTS AND SHARES IN OTHER ENTERPRISES (CONTINUED)

Participating Interests and Shares in other enterprises (continued)

OTHER INVESTMENTS AND DEPOSITS, ALLOCATION DEFERRED CHARGES AND ACCRUED INCOME

STATEMENT OF CAPITAL AND SHAREHOLDING STRUCTURE

PROVISIONS FOR OTHER LIABILITIES AND CHARGES

STATEMENT OF AMOUNTS PAYABLE, ACCRUED CHARGES AND DEFERRED INCOME

OPERATING RESULTS

FINANCIAL AND EXTRAORDINARY RESULTS

INCOME AND COSTS OF EXCEPTIONNAL SIZE OR OF EXCEPTIONNAL OCCURENCE

INCOME TAXES AND OTHER TAXES

RIGHTS AND COMMITMENTS NOT REFLECTED IN THE BALANCE SHEET

SETTLEMENT WITH REGARD TO THE COMPLEMENTARY RETREAT OR SURVIVAL PENSION FOR STAFF AND BOARD MEMBERS

Concise description

Measures taken to cover the related costs

RELATIONSHIPS WITH AFFILIATED ENTERPRISES AND ENTERPRISES LINKED BY PARTICIPATING INTERESTS

FINANCIAL RELATIONSHIPS WITH

Auditors or people they are linked to

DERIVATIVES NOT MEASURED AT FAIR VALUE

VOOR IEDERE CATEGORIE AFGELEIDE FINANCIËLE INSTRUMENTEN DIE NIET GEWAARDEERD ZIJN OP BASIS VAN REËLE WAARDE

INFORMATION RELATING TO CONSOLIDATED ACCOUNTS

VALUATION RULES

D. Cash flow hedge : FX risks

E. Cash flow hedge : interest rate risks

F. Net investment hedge

OTHER DOCUMENTS TO BE FILED UNDER BELGIAN COMPANY LAW

1. Major events during the financial year 2016

1.1 Early redemption of the perpetual bond

1.2 Events following the 2015 Group structure changes

1.3 Capital increases of subsidiaries

1.4 Settlement of outstanding Belgian commercial paper ("BCP") position

1.5 Transfer of obligations under 2016 Performance Share Plan from UCB SA/NV to UCB Fipar SA/NV

1.6 Transfer of treasury operations

Acquisition of UCB affiliates owned by UCB Lux S.A.

Assignment of intra-group receivables

Assignment of loans from the European Investment Bank ("EIB")

Early repayment of loan agreements between UCB SA/NV and UCB Lux S.A.

Liquidation of UCB Lux S.A.

1.7 Transactions in Own Shares

1.8 Redemption of senior unsecured bonds

1.9 Incorporation of UCB Ventures SA/NV

2. Change in accounting policies

Accounting treatment of derivatives

Accounting treatment of fair value adjustments on loans being acquired

4. Major events after the balance sheet date

5. Conflicts of interest met during the financial year

6. Financial information

Results at 31 December 2016

Result appropriation

Balance Sheet items at 31 December 2016

7. Changes to the composition of the Board

8. Financial instruments, risks of credit, risks of liquidity and risks of treasury

9. Change of control

10. Activities in the area of research and development

11. Branches of UCB SA/NV

12. Corporate Governance Statement

STATEMENT OF THE PERSONS EMPLOYED

EMPLOYEES FOR WHOM THE ENTREPRISE SUBMITTED A DIMONA DECLARATION OR WHO ARE RECORDED IN THE GENERAL PERSONNEL REGISTER

EMPLOYEES FOR WHOM THE ENTREPRISE SUBMITTED A DIMONA DECLARATION OR WHO ARE RECORDED IN THE GENERAL PERSONNEL REGISTER (continued)

HIRED TEMPORARY STAFF AND PERSONNEL PLACED AT THE ENTERPRISE'S DISPOSAL

LIST OF PERSONNEL MOVEMENTS DURING THE PERIOD

UCB Annual Report 2016